StockData
Oruka Therapeutics, Inc. logo

Oruka Therapeutics, Inc. (ORKA) stock

ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$96.32−2.92 (-2.94%)

Close on Nov 17, 2026Market cap $6.38BP/E –Yield –

Oruka Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Oruka Therapeutics

Oruka Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Oruka Therapeutics figures

See a number that looks wrong?